Odds Ratio: 2.41 (95% CI 1.23–4.69)
Accurate frailty assessment tools are needed to appropriately select patients for TAVR and direct inappropriate candidates to medical therapy or palliative care.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2022) conducted an editorial in Severe aortic stenosis (n=431). Frailty (Groningen Frailty Indicator ≥ 4/15) vs. Non-frail was evaluated on 1-year mortality post-TAVR (OR 2.41, 95% CI 1.23, 4.69).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: